H.R. 6000 117th Congress
Cures 2.0 Act
- Health
- Sponsor: Rep. DeGette, Diana [D-CO-1]
- Congress.gov ↗
Latest action, Jan 4, 2022: Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
100 cosponsors
Sponsored by Rep. DeGette, Diana [D-CO-1] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
- Democrat
- Republican
- Independent
Referred to: House: Agriculture Committee; House: Armed Services Committee; House: Budget Committee; House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Homeland Security Committee; House: Judiciary Committee; House: Natural Resources Committee; House: Science, Space, and Technology Committee; House: Veterans' Affairs Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
All 25 of 173 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | 5 | $1.5M | Q4 2021 | Q3 2022 | yes | |
| ALLIANCE FOR CELL THERAPY NOW | TODD STRATEGY GROUP | 5 | $110K | Q4 2021 | Q3 2022 | yes |
| ALZHEIMER'S ASSOCIATION | 5 | $3.3M | Q4 2021 | Q3 2022 | yes | |
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 5 | $2.3M | Q4 2021 | Q3 2022 | yes | |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | 5 | $1.5M | Q4 2021 | Q3 2022 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 5 | $1.2M | Q4 2021 | Q3 2022 | yes | |
| AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) | RAMPY NORTHRUP LLC | 5 | $280K | Q4 2021 | Q3 2022 | yes |
| AMERICAN MEDICAL ASSOCIATION | 5 | $25.3M | Q4 2021 | Q3 2022 | yes | |
| AMERICAN SOCIETY FOR MICROBIOLOGY | 5 | $250K | Q4 2021 | Q3 2022 | yes | |
| AMERICAN SOCIETY OF HEMATOLOGY | 5 | $150K | Q4 2021 | Q3 2022 | yes | |
| AMERICAN SOCIETY OF HEMATOLOGY | ARTEMIS POLICY GROUP LLC | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| ARTHRITIS FOUNDATION | 5 | $375K | Q4 2021 | Q3 2022 | yes | |
| ARUP LABORATORIES, INC. | VAN SCOYOC ASSOCIATES | 5 | $150K | Q4 2021 | Q3 2022 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 5 | $4.8M | Q4 2021 | Q3 2022 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | RAMPY NORTHRUP LLC | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| ASTRAZENECA PHARMACEUTICALS LP | RAMPY NORTHRUP LLC | 5 | $0 | Q4 2021 | Q3 2022 | — |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 5 | $16.6M | Q4 2021 | Q3 2022 | yes | |
| BOSTON SCIENTIFIC CORPORATION | 5 | $1.9M | Q4 2021 | Q3 2022 | yes | |
| CHILD NEUROLOGY FOUNDATION | ARTEMIS POLICY GROUP LLC | 5 | $116K | Q4 2021 | Q3 2022 | yes |
| COLLEGE OF AMERICAN PATHOLOGISTS | 5 | $576K | Q4 2021 | Q3 2022 | yes | |
| CURE SMA | 5 | $265K | Q4 2021 | Q3 2022 | yes | |
| DANA FARBER CANCER INSTITUTE | VAN SCOYOC ASSOCIATES | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| DANA-FARBER CANCER INSTITUTE | 5 | $481K | Q4 2021 | Q3 2022 | yes | |
| DAVITA INC | 5 | $5.0M | Q4 2021 | Q3 2022 | yes | |
| EXACT SCIENCES | 5 | $2.1M | Q4 2021 | Q3 2022 | yes |